¼¼°èÀÇ ÁöÇ÷Á¦ ½ÃÀå º¸°í¼­(2025³â)
Hemostats Global Market Report 2025
»óǰÄÚµå : 1659129
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,371,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,209,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,048,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÁöÇ÷Á¦ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â CAGR 6.8%·Î 46¾ï 7,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø±â°£ÀÇ ¼ºÀåÀº ±ä±Þ»çÅ ´ëºñ¿Í À¯Çà ´ëÀÀ, ¼¼°èÀÇ ÇコÄɾî ÀÎÇÁ¶ó °³¹ß, Àúħ½À ¼ö¼ú ¼ö¿ä Áõ°¡, ´Ù¾çÇÑ Àü¹® ºÐ¾ß¿¡¼­ÀÇ ¿ëµµ È®´ë, »ýüÀûÇÕ¼ºÀÇ Á߽à µî¿¡ ±âÀÎÇÑ´Ù°í »ý°¢µË´Ï´Ù. ¿¹Ãø±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Á¦Ç°ÀÇ Çõ½Å, ÁöÇ÷±â¼úÀÇ Áøº¸, Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ÁÖ¸ñ µîÀÌ ÀÖ½À´Ï´Ù.

¼ö¼ú Áõ°¡´Â ÁöÇ÷Á¦ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿Ü°úÀû Ä¡·á¶õ »ç¶÷ÀÌ º´¸®ÇÐÀû »óŸ¦ °Ë»çÇϰųª Ä¡·áÇϱâ À§ÇØ »ç¿ëÇÏ´Â ¸ðµç ÇüÅÂÀÇ Ä§½ÀÀû Ä¡·á¸¦ ¸»ÇÕ´Ï´Ù. ÁöÇ÷Á¦´Â ¼ö¼ú Áß ÃâÇ÷À» ¹æÁöÇÏ´Â µ¥ »ç¿ëµÇ¹Ç·Î ¼ö¼ú¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 9¿ù ·¹¹Ù³íÀ» °ÅÁ¡À¸·Î ÇÏ´Â ¼ºÇü¿Ü°ú Àü¹®ÀÇÀÇ Àü¹®Á¶Á÷ÀÎ ±¹Á¦¹Ì¿ëÇü¼º¿Ü°úÇÐȸ¿¡ µû¸£¸é 2022³â¿¡ ¼ºÇü¿Ü°úÀÇ¿¡ ÀÇÇØ ÇàÇØÁø ¼ö¼úÀº ÀüüÀûÀ¸·Î 11.2% Áõ°¡ÇÏ¿© ¼¼°è 1,490¸¸ °Ç ÀÌ»óÀÇ ¼ö¼ú°ú 1,880¸¸ °Ç ÀÌ»óÀÇ ºñ¿Ü°ú ¼ö¼úÀÌ ÀÌ·ïÁ³½À´Ï´Ù. ¶ÇÇÑ, Áö³­ Á¶»ç ÀÌÈÄ ¼ö¼ú ¹× ºñ¼ö¼ú ½Ã¼ú ¸ðµÎ °¢°¢ 16.7% ¹× 7.2%Áõ°¡¼¼¸¦ º¸¿´½À´Ï´Ù. µû¶ó¼­ ¼ö¼ú Áõ°¡´Â ÁöÇ÷Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

ÁöÇ÷Á¦ ½ÃÀåÀº ¹«·á ¼ö¼úÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÇÇØ Ãß°¡ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ȯÀÚ¿¡°Ô ¿ä±ÝÀ» ºÎ°úÇÏÁö ¾Ê°í ¼öÇàµÇ´Â ¹«·á ¼ö¼úÀº °æÁ¦ÀûÀ¸·Î Ãë¾àÇÑ »ç¶÷µéÀÇ Ä¡·á ºÎ´ãÀ» ÁÙÀÔ´Ï´Ù. PubMedÀÇ 2022³â 5¿ù ±â»ç¿¡¼­ º¸°íµÈ ¹Ù¿Í °°ÀÌ Àεµ Àü¿ªÀÇ 3Â÷ ÀÇ·á º´¿ø¿¡¼­ ½Ç½ÃµÈ ¼³¹® Á¶»ç¿¡¼­ »ó´çÇÑ ¿µÇâÀÌ ÀÖÀ½ÀÌ ¹àÇôÁ³½À´Ï´Ù. ÀÀ´äÀÚÀÇ ¾à 41.7%°¡ º¹°­°æ ¼ö¼ú°ú °³º¹ ¼ö¼úÀ» ¸ðµÎ ¶È°°ÀÌ Çϰí ÀÖÀ¸¸ç, ÁöÇ÷Á¦ÀÇ ´Ù¾çÇÑ ÀÀ¿ëÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ¼ö¼ú ¼ö¿äÀÇ ±ÞÁõ, ƯÈ÷ ÁöÇ÷Á¦ÀÇ »ç¿ë µ¿ÇâÀº ÁöÇ÷Á¦ ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿¡ À־ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°,±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

A hemostat is a surgical tool employed in various surgical procedures to control or compress bleeding vessels, facilitating the treatment of wounds and aiding in visualizing deeper regions during surgeries.

There are several types of hemostats, including thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Thrombin-based hemostats are used to control and reduce blood loss during surgical procedures, either in conjunction with or as an alternative to traditional surgical techniques. Thrombin is an enzyme that breaks down fibrinogen into fibrin, promoting blood clotting. Examples of active hemostats include topical (bovine) thrombin (Thrombin-JMI), topical (human) thrombin (Evithrom), and topical (recombinant) thrombin (Recothrom). They are available in various forms, such as active hemostats, passive hemostats, combination hemostats, and others. Formulations include matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats. These hemostats find applications in orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other medical procedures.

The hemostats market research report is one of a series of new reports from The Business Research Company that provides hemostats market statistics, including hemostats industry global market size, regional shares, competitors with a hemostats market share, detailed hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats industry. This hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats market size has grown strongly in recent years. It will grow from $3.37 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications.

The hemostats market size is expected to see strong growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to emergency preparedness and pandemic response, global healthcare infrastructure development, growing demand for minimally invasive surgeries, expanding applications in various specialties, focus on biocompatibility. Major trends in the forecast period include product innovations, advancements in hemostatic technologies, focus on minimally invasive surgeries.

An increase in surgical procedures is expected to propel the growth of the hemostat market going forward. Surgical procedures refer to all forms of invasive treatments that are used on a person to investigate or treat a pathological condition. Hemostats are essential for surgical procedures as they are used to prevent blood loss while performing surgery. For instance, in September 2023, according to the International Society of Aesthetic Plastic Surgery, a Lebanon-based professional organization for board-certified plastic surgeons, there was an 11.2% overall increase in procedures performed by plastic surgeons in 2022, with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide. Additionally, both surgical and non-surgical procedures showed increases since the last survey (16.7% and 7.2% respectively). Therefore, an increase in surgical procedures is driving the growth of the hemostat market.

The hemostat market is poised for further growth, driven by government initiatives aimed at providing free surgeries. Free surgeries, performed without charging patients, alleviate the treatment burden on the economically disadvantaged. A survey conducted in tertiary care hospitals across India, as reported in a May 2022 article on PubMed, revealed a significant impact. Approximately 41.7% of respondents performed both laparoscopic and open procedures equally, demonstrating the diverse application of hemostats. The surge in surgical demand, especially with the trend toward hemostat usage, emphasizes the pivotal role of government initiatives in propelling the hemostat market's growth.

Technological advancement emerges as a key trend shaping the hemostat market, with major companies investing in new technologies and research and development efforts. Baxter, a prominent US-based healthcare company, exemplifies this trend through the launch of PERCLOT Absorbable Hemostatic Powder in March 2022. This passive, absorbable hemostatic powder is designed for patients with intact coagulation to address mild bleeding, providing surgeons with a versatile tool for bleeding control. The emphasis on technological innovation highlights the commitment to optimizing patient care and expanding the range of hemostatic solutions.

Major companies in the hemostat market are strategically engaging in partnerships and collaborations, particularly with start-ups and mid-sized companies, to enhance their product and service offerings. In May 2023, Olympus, a Japan-based manufacturer of optics and reprography products, expanded its partnership with Endoclot, a US-based medical device company. This collaboration aims to launch hemostatic agents, contributing to safe treatment in gastrointestinal procedures. By entering strategic partnerships, companies like Olympus seek to broaden their product portfolios and geographical reach, ultimately elevating the standard of care and improving patient outcomes in the hemostat market.

In December 2022, Integra LifeSciences, a US-based medical technology company, acquired Surgical Innovation Associates for $150 million. This acquisition allows Integra LifeSciences Holding Corporation to enhance its product portfolio, expand its market reach, and strengthen its position in the medical technology sector. Surgical Innovation Associates is a US-based company specializing in providing advanced surgical technologies and solutions.

Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc., Metalcraft Solutions Inc.

North America was the largest region in the hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemostat market consists of sales of cellulose based and thrombin-based hemostats. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Hemostats Market Characteristics

3. Hemostats Market Trends And Strategies

4. Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hemostats Growth Analysis And Strategic Analysis Framework

6. Hemostats Market Segmentation

7. Hemostats Market Regional And Country Analysis

8. Asia-Pacific Hemostats Market

9. China Hemostats Market

10. India Hemostats Market

11. Japan Hemostats Market

12. Australia Hemostats Market

13. Indonesia Hemostats Market

14. South Korea Hemostats Market

15. Western Europe Hemostats Market

16. UK Hemostats Market

17. Germany Hemostats Market

18. France Hemostats Market

19. Italy Hemostats Market

20. Spain Hemostats Market

21. Eastern Europe Hemostats Market

22. Russia Hemostats Market

23. North America Hemostats Market

24. USA Hemostats Market

25. Canada Hemostats Market

26. South America Hemostats Market

27. Brazil Hemostats Market

28. Middle East Hemostats Market

29. Africa Hemostats Market

30. Hemostats Market Competitive Landscape And Company Profiles

31. Hemostats Market Other Major And Innovative Companies

32. Global Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemostats Market

34. Recent Developments In The Hemostats Market

35. Hemostats Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â